Products

Recombinant Anti-FCER2 Antibody (Fc glycosylation/Non fucosylated) (Gly-157LC-1)

This product is a non-fucosylated chimeric (primate/human) monoclonal antibody. The antibody with enhanced ADCC specficfically binds to human CD23 and can be potentially used in the treatment of chronic lymphocytic leukemia.      

Glyco-engineering
Classification
Fc glycosylation/Non fucosylated
Glycosylation site
Fc region
Glycosylation Type
N-glycosylation
Activity
Enhanced ADCC
Specifications
Target
CD23 (Cluster of differentiation-23)
Host Animal
Human
Derivation
Chimeric (primate/human)
Type
Chimeric antibody (primate/human)
Specificity
Human
Applications
ELISA
Target
Alternative Names
FCER2; Fc fragment of IgE receptor II; CD23; FCE2; CD23A; IGEBF; CLEC4J; BLAST-2
Related Disease
Chronic lymphocytic leukemia
Entrez Gene ID
2208
UniProt ID
P06734

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-871-5806
Fax: 1-631-207-8356
Email:

45-1 Ramsey Road, Shirley, NY 11967, USA     Tel: 1-631-871-5806    Fax: 1-631-207-8356    Email:
Terms of Service-Privacy Policy     © 2007 - 2017 Creative-Biolabs All Rights Reserved